Medigen Vaccine Biologics Corporation (TPEX:6547)
Taiwan · Delayed Price · Currency is TWD 47.70
-0.10 (-0.21%)
Jul 16, 2026, 1:30 PM CST
Medigen Vaccine Biologics Market Cap
Medigen Vaccine Biologics has a market cap or net worth of 15.71 billion as of July 16, 2026. Its market cap has increased by 9.13% in one year.
Market Cap
15.71B
Enterprise Value
14.64B
Revenue
603.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
47.70
Market Cap Chart
Since August 6, 2015, Medigen Vaccine Biologics's market cap has increased from 2.83B to 15.71B, an increase of 454.29%. That is a compound annual growth rate of 16.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 15.71B | 26.62% |
| Dec 31, 2025 | 12.41B | 4.72% |
| Dec 31, 2024 | 11.85B | -48.55% |
| Dec 29, 2023 | 23.04B | 1.10% |
| Dec 30, 2022 | 22.78B | -64.20% |
| Dec 30, 2021 | 63.65B | 192.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sunmax Biotechnology | 20.75B |
| ACRO Biomedical | 18.30B |
| TaiMed Biologics | 17.54B |
| Ever Supreme Bio Technology | 16.49B |
| Lumosa Therapeutics | 16.01B |
| TCM Biotech International | 14.35B |
| EirGenix | 14.11B |
| Gongwin Biopharm Holdings | 12.73B |